Tag: multiple myeloma
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments in multiple myeloma patients with…
Multiple Myeloma Treatment Paradigm Shift: New Guidelines Redefine Early Relapse
New England Journal of Medicine editorial calls for fundamental changes to multiple myeloma early relapse definitions, arguing biological markers should…
Submit Your Paper to GMJ
No APC until January 2027.